Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2022 R33 CA21-004 MERAJVER, SOFIA DIANA UNIVERSITY OF MICHIGAN AT ANN ARBOR Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence Active
2021 R33 RFA-CA-20-020 HAUN, JERED BRACKSTON UNIVERSITY OF CALIFORNIA-IRVINE Microfluidic tumor tissue processing platform for single cell diagnostics Active
2023 R33 RFA-CA-22-002 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA Combining Machine Learning and Nanofluidic Technology for The Multiplexed Diagnosis of Pancreatic Adenocarcinoma Active
2022 R33 CA21-004 ADEY, ANDREW OREGON HEALTH & SCIENCE UNIVERSITY Accessible high-throughput single-cell genome sequencing Active
2021 R33 RFA-CA-20-018 SEELIG, GEORG UNIVERSITY OF WASHINGTON Joint receptor and protein expression immunophenotyping through split-pool barcoding Active
2023 R33 RFA-CA-22-004 LEVENSON, RICHARD M UNIVERSITY OF CALIFORNIA AT DAVIS CoreView and FIBI for rapid-onsite evaluation and molecular profiling of core-needle breast biopsies. Active
2022 R33 CA21-004 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic Control of Tumor Initiation and Tumor Progression in vivo Active
1999 R43 PAR-98-066 CHANG, HWAI W STRATAGENE GENETIC SELECTION FOR PROTEASES AND THEIR SUBSTRATES Complete
2001 R43 PAR-99-101 KOGON, ALEX A BIOLINX, LLC SELECTION OF THE BEST LIGANDS FROM COMBINATORIAL LIBRARY Complete
2004 R33 PAR-01-106 SINGER, ROBERT H ALBERT EINSTEIN COL OF MED YESHIVA UNIV FISH AND CHIPS: SINGLE CELL EXPRESSION OF CANCER GENES Complete
2007 R33 RFA-CA-07-001 MILOSAVLJEVIC, ALEKSANDAR BAYLOR COLLEGE OF MEDICINE MULTIPLEXED METHODS FOR THE STUDY OF CHROMOSOMAL ABERRATIONS IN CANCER Complete
2010 R21 RFA-CA-09-008 CHIU, DANIEL T UNIVERSITY OF WASHINGTON HIGH SENSITIVITY DETECTION AND ISOLATION OF CIRCULATING TUMOR CELLS Complete
2014 R21 RFA-CA-13-003 SEIBEL, ERIC J UNIVERSITY OF WASHINGTON NEEDLE BIOPSY PRESERVATION AND PREPARATION FOR RAPID 3D PATHOLOGY OF PANCREAS Complete
2017 R33 RFA-CA-16-002 KELLEY, SHANA O UNIVERSITY OF TORONTO Development and validation of nanoparticle-mediated microfluidic profiling approach for rare cell analysis Complete
2001 R21 PAR-99-102 ZHOU, PENGBO WEILL MEDICAL COLLEGE OF CORNELL UNIV PROTEIN KNOCKOUT TECHNOLOGY/MOLECULAR ANALYSIS OF CANCER Complete
2003 R33 PAR-01-106 FURGE, KYLE A VAN ANDEL RESEARCH INSTITUTE COMPARATIVE GENOMIC ANALYSIS OF MICROARRAY DATA Complete
2006 R44 RFA-CA-06-005 LU, PETER S. ARBOR VITA CORPORATION A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES Complete
2009 R21 RFA-CA-08-009 SIMBERG, DIMITRI UNIVERSITY OF CALIFORNIA SAN DIEGO ISOLATION OF RARE CIRCULATING TUMOR CELLS FROM BLOOD USING MICROBUBBLES Complete
2013 R21 RFA-CA-13-001 WANG, ZHENGHE CASE WESTERN RESERVE UNIVERSITY NEXT-GENERATION MOUSE GENE-TARGETING TECHNOLOGY TO MODEL TUMORIGENESIS Complete
2016 R43 PAR-13-327 OUELLETTE, STEVEN BRADLEY KINASENSE, LLC DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY Complete
2020 R44 PAR-18-303 FRIEDA, KIRSTEN SPATIAL GENOMICS, INC. Spatial and single cell analysis of tumor microenvironment by seqFISH+ Complete
2000 R33 PAR-99-102 POOLA, INDIRA NONE HOWARD UNIVERSITY MOLECULAR ASSAY FOR ESTROGEN RECEPTORS IN BREAST TUMORS Complete
2002 R43 PAR-01-105 MARTIN, MARK MIRARI BIOSCIENCES, INC. MICROWAVE-ENHANCED LUMINESCENCE TO DETECT GROWTH FACTORS Complete
2006 R21 RFA-CA-06-002 TSOURKAS, ANDREW UNIVERSITY OF PENNSYLVANIA NOVEL PROBE FOR QUANTITATIVE IMAGING OF GENE EXPRESSION Complete
2008 R44 RFA-CA-07-041 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS Complete
2012 R21 RFA-CA-12-002 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROSYSTEMS FOR TARGETING LEVY WALKS IN METASTATIC CANCER CELLS Complete
2015 R43 PAR-13-327 ORBAI, LUCIAN CELL DATA SCIENCES, INC. RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS Complete
2019 R21 RFA-CA-18-002 ANGEL, PEGGY M MEDICAL UNIVERSITY OF SOUTH CAROLINA Enzymatic Tools for 2D Tissue Localized and Deeper Proteomic Sequencing of Cancer Stromal Proteins Complete
2000 R21 PAR-99-100 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IN VIVO IMAGING OF MATRIX METALLOPROTEASE Complete
2002 R21 PAR-99-100 SOMMER, STEVE SEEV CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CARBON NANOTUBES: ARTIFICAL GELS FOR MUTATIONS DETECTION Complete
2005 R21 RFA-CA-05-003 HAAB, BRIAN B. VAN ANDEL RESEARCH INSTITUTE LONGITUDINAL CANCER-SPECIFIC SERUM PROTEIN SIGNATURES Complete
2008 R21 RFA-CA-07-035 RABINOWITZ, JOSHUA D PRINCETON UNIVERSITY MASS SPECTROMETRY METHODS FOR PROBING METABOLIC DYNAMICS IN NORMAL & CANCER CELLS Complete
2011 R21 RFA-CA-10-005 LAI, JONATHAN ALBERT EINSTEIN COLLEGE OF MEDICINE METHODS TO IDENTIFY HIGH-AFFINITY ANTIBODIES THAT TARGET TUMOR-ASSOCIATED GLYCANS Complete
2015 R21 RFA-CA-14-003 WELSH, JOHN T VACCINE RESEARCH INSTITUTE OF SAN DIEGO A MOLECULAR METHOD TO DETERMINE ISOFORM FREQUENCIES IN RNA-SEQ Complete
2018 R33 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors Complete
1999 R43 PAR-98-066 MILLER, JEFFREY E. IVS TECHNOLOGIES, LLC NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS Complete
2001 R43 PAR-99-101 SHEN, SHANXIANG PROTIVERIS, INC. MICROCANTILEVER ARRAY DEVICE FOR PROTEIN PROFILING Complete
2004 R42 PAR-01-105 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2007 R33 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2010 R21 RFA-CA-09-008 KASSIS, AMIN I HARVARD MEDICAL SCHOOL NOVEL BLOOD ASSAY FOR LUNG CANCER DETECTION Complete
2014 R21 RFA-CA-13-003 PETRITIS, KONSTANTINOS PHOENIX CHILDREN'S HOSPITAL PRESERVATION OF DRIED PLASMA SPOTS FOR DOWNSTREAM PROTEOMIC APPLICATIONS Complete
2017 R33 RFA-CA-16-002 WANG, YINGXIAO UNIVERSITY OF CALIFORNIA, SAN DIEGO Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells Complete
2001 R33 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2003 R33 PAR-01-106 COLLINS, COLIN C UNIVERSITY OF CALIFORNIA SAN FRANCISCO DEVELOPMENT OF ESP: STRUCTURAL & FUNCTIONAL ONCOGENOMICS Complete
2006 U43 RFA-CA-06-006 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES Complete
2009 R21 RFA-CA-08-009 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTECHNOLOGY FOR ONE STEP CONCENTRATION AND PRESERVATION OF LABILE BIOMARKERS I Complete
2013 R33 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete
2016 R43 PAR-13-327 KLUGE, JONATHAN AUGUST VAXESS TECHNOLOGIES, INC. SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS Complete
2020 R43 PAR-18-303 WANG, SHA VIVID TECHNOLOGIES New specific and rapid assay for in situ apoptosis labeling for cancer studies Complete
2000 R41 PAR-98-066 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION Complete

Pages